247 related articles for article (PubMed ID: 6201026)
1. [Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].
Golovkin VI; Ankhimova ES; Morozov VG; Khavinson VG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):179-82. PubMed ID: 6201026
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova LA
Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
[TBL] [Abstract][Full Text] [Related]
3. [Correction of immunologic disorders in patients with burns].
Shkrob LO; Lukoianova TN; Vishnevskaia SM; Panova IuM; Kashin IuD
Khirurgiia (Mosk); 1990 Feb; (2):116-9. PubMed ID: 2335880
[TBL] [Abstract][Full Text] [Related]
4. [Principles for assessing and correcting secondary immunological deficiency].
Zemskov AM; Provotorov VM; Zemskov VM
Ter Arkh; 1984; 56(10):70-4. PubMed ID: 6335309
[TBL] [Abstract][Full Text] [Related]
5. [Thymic polypeptide factor--thymalin in experiments and in clinical use].
Sofronov BN; Morozov VG; Khavinson VKh; Belokrylov GA
Fiziol Cheloveka; 1984; 10(2):229-33. PubMed ID: 6335878
[No Abstract] [Full Text] [Related]
6. Thymic hormone in the treatment of cancer.
Dardeene M; Bach JF
Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955
[No Abstract] [Full Text] [Related]
7. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
[TBL] [Abstract][Full Text] [Related]
8. [Circadian variations in the metabolic reaction of human blood lymphocytes to hormonal stimuli in normal conditions and during development of an immunodeficiency].
Trufakin VA; Shurlygina AV; Dergacheva TI; Litvinenko GI
Biull Eksp Biol Med; 1995 Feb; 119(2):181-3. PubMed ID: 7670047
[No Abstract] [Full Text] [Related]
9. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
[No Abstract] [Full Text] [Related]
10. [Homeostatic effect of thymalin in multiple sclerosis].
Akimov GA; Golovkin VI; Khavinson VKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):16-9. PubMed ID: 2160161
[TBL] [Abstract][Full Text] [Related]
11. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
Hamilton G; Zöch G; Rath T; Meissl G
Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
[No Abstract] [Full Text] [Related]
12. [Use of thymalin in the complex treatment of infantile cerebral palsy].
Mamonova IP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1468-71. PubMed ID: 3878053
[TBL] [Abstract][Full Text] [Related]
13. [Thymalin as a modulator of immunogenesis and hemostasis].
Kuznik BI; Budazhabon GB; Budazhabon NG; Morozov VG; Pinelis IS
Farmakol Toksikol; 1984; 47(1):67-71. PubMed ID: 6546722
[TBL] [Abstract][Full Text] [Related]
14. Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
Aiuti F; Businco L; Rossi P; Quinti I
Lancet; 1980 Jan; 1(8159):91. PubMed ID: 6101433
[No Abstract] [Full Text] [Related]
15. [Thymopentin and immune response in patients with cancer].
Petronella P; Ferrone R; Freda F; Valeriani G
Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
[TBL] [Abstract][Full Text] [Related]
16. Role of thymic hormones in neuroimmunomodulation. Their use in patients with phobic disorders.
Covelli V; Munno I; Altamura M; Decandia P; Pellegrino NM; Marcuccio C; Caradonna L; Jirillo E
Acta Neurol (Napoli); 1991 Oct; 13(5):457-66. PubMed ID: 1776534
[TBL] [Abstract][Full Text] [Related]
17. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
Kikot' VA; Dziubko NIa
Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
[TBL] [Abstract][Full Text] [Related]
18. [Development of an experimental tuberculous process in the presence of immune deficiency and immunostimulation].
Shcherbakova NM; Aleksandrova AE; Morozov VG; Podosinnikov IS; Khavinson VKh
Biull Eksp Biol Med; 1981 Sep; 92(9):320-2. PubMed ID: 6895337
[TBL] [Abstract][Full Text] [Related]
19. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
